Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Fatima A. Rangwala
Honoraria - Roche/Genentech (I)
Johanna C. Bendell
No relevant relationships to disclose
Mark Kozloff
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Christy Arrowood
No relevant relationships to disclose
Jennifer Meadows
No relevant relationships to disclose
Sandra Ellen Tourt-Uhlig
No relevant relationships to disclose
Jennifer Murphy
No relevant relationships to disclose
Kellen Meadows
No relevant relationships to disclose
Michael Morse
Consultant or Advisory Role - Novartis; Roche/Genentech
Honoraria - Novartis; Roche/Genentech
Research Funding - Novartis
Hope Elizabeth Uronis
Research Funding - Roche/Genentech
Shiaowen David Hsu
No relevant relationships to disclose
Yousuf Zafar
Honoraria - Roche/Genentech
Herbert Hurwitz
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Novartis; Roche/Genentech